Q1 2021 13F Holders as of 3/31/2021
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
92
-
Total 13F shares, excl. options
-
22.4M
-
Shares change
-
+6.76M
-
Total reported value, excl. options
-
$209M
-
Value change
-
+$69.5M
-
Put/Call ratio
-
1.14
-
Number of buys
-
50
-
Number of sells
-
-45
-
Price
-
$9.34
Significant Holders of Niagen Bioscience, Inc. - COM NEW (NAGE) as of Q1 2021
116 filings reported holding NAGE - Niagen Bioscience, Inc. - COM NEW as of Q1 2021.
Niagen Bioscience, Inc. - COM NEW (NAGE) has 92 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 22.4M shares
.
Largest 10 shareholders include Yong Rong (HK) Asset Management Ltd (4.13M shares), BlackRock Inc. (3.17M shares), VANGUARD GROUP INC (2.34M shares), BANK OF AMERICA CORP /DE/ (1.43M shares), ICONIQ Capital, LLC (1.3M shares), MILLENNIUM MANAGEMENT LLC (909K shares), Invesco Ltd. (812K shares), GEODE CAPITAL MANAGEMENT, LLC (736K shares), STATE STREET CORP (728K shares), and Uniplan Investment Counsel, Inc. (671K shares).
This table shows the top 92 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.